Home › Cancro ovarico › Florida › Jacksonville
Studi clinici su Cancro ovarico a Jacksonville, FL
16 studi su Cancro ovarico cercano partecipanti presso sedi a Jacksonville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Mayo Clinic in Florida, Jacksonville
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
In reclutamentoFase 2
- Mayo Clinic in Florida, Jacksonville
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
In reclutamentoStudio osservazionale
- Mayo Clinic, Jacksonville
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Jacksonville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Mayo Clinic Jacksonville, Jacksonville
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- Baptist MD Anderson Cancer Center, Jacksonville
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
In reclutamentoFase 2
- Mayo Clinic Jacksonville, Jacksonville
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
In reclutamentoFase 4
- University of Florida Jacksonville, Jacksonville
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Mayo Clinic (Florida), Jacksonville
- Cancer Specialists of North Florida, Jacksonville
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
In reclutamentoFase 3
- Mayo Clinic Florida, Jacksonville
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
In reclutamentoFase 1/2
- Mayo Clinic - Jacksonville, Jacksonville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Mayo Clinic, Jacksonville
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- Mayo Clinic, Jacksonville
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
In reclutamentoFase 2
- Mayo Clinic Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Jacksonville
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #15, Jacksonville
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Jacksonville
- Cancro al seno40 studi
- Cancro del polmone non a piccole cellule39 studi
- Cancro (tutti i tipi)29 studi
- Cancro metastatico28 studi
- Cancro colorettale27 studi
- Cancro alla prostata26 studi
- Obesità25 studi
- Insufficienza cardiaca21 studi
- Cancro pancreatico20 studi
- Sovrappeso19 studi
- Mieloma multiplo18 studi
- Cancro ai polmoni17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.